دورية أكاديمية
أعرض في EDS

Using a Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO 2 R) System in the Management of Refractory Status Asthmaticus: A Case Series.

التفاصيل البيبلوغرافية
العنوان: Using a Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO 2 R) System in the Management of Refractory Status Asthmaticus: A Case Series.
المؤلفون: Fox S; From the Department of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Mehkri O; Department of Critical Care, Cleveland Clinic, Cleveland, Ohio., Latifi M; Department of Critical Care, Cleveland Clinic, Cleveland, Ohio., Krishnan S; Department of Critical Care, Cleveland Clinic, Cleveland, Ohio., Dill T; Clinical Operations, ALung Technologies Inc., Pittsburgh, Pennsylvania., Duggal A; Department of Critical Care, Cleveland Clinic, Cleveland, Ohio.
المصدر: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2024 May 01; Vol. 70 (5), pp. e70-e74. Date of Electronic Publication: 2023 Oct 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-943X (Electronic) Linking ISSN: 10582916 NLM ISO Abbreviation: ASAIO J Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Philadelphia, PA : Published for the Society by J.B. Lippincott Co., c1992-
مواضيع طبية MeSH: Status Asthmaticus*/therapy , Carbon Dioxide* , Extracorporeal Membrane Oxygenation*/methods , Extracorporeal Membrane Oxygenation*/instrumentation , Hypercapnia*/therapy , Hypercapnia*/etiology, Humans ; Retrospective Studies ; Male ; Adult ; Female ; Middle Aged ; Treatment Outcome ; Aged ; Acidosis, Respiratory/etiology ; Acidosis, Respiratory/therapy
مستخلص: Rescue treatments for status asthmaticus remain limited. Current literature has mainly focused on using extracorporeal membrane oxygenation (ECMO) as a primary modality of care for these patients. Low-flow extracorporeal CO 2 removal (ECCO 2 R) systems are an attractive option to improve refractory hypercapnic respiratory acidosis because of status asthmaticus. This is a retrospective case series that describes the feasibility and efficacy of the use of a low-flow ECCO 2 R device, the Hemolung Respiratory Assist System, in patients with refractory hypercapnic respiratory failure because of status asthmaticus. Eight patients were treated with the Hemolung Respiratory Assist System in eight separate locations globally. Seven (88%) of the patients survived to discharge in this case series. Both CO 2 and pH resolution were seen in 6 hours. None of the ECCO 2 R runs were stopped because of mechanical- or device-related complications. One patient necessitated transition to ECMO. Low-flow ECCO 2 R systems is an effective option for resolution of refractory hypercapnia in status asthmaticus. Use of these systems are also associated with a survival rate of close to 90% in patients with status asthmaticus.
(Copyright © ASAIO 2023.)
References: Louie S, Morrissey BM, Kenyon NJ, Albertson TE, Avdalovic M: The critically ill asthmatic—from ICU to discharge. Clin Rev Allergy Immunol. 43: 30–44, 2012.
Zakrajsek JK, Min SJ, Ho MP: Extracorporeal membrane oxygenation for refractory asthma exacerbations with respiratory failure. Chest. 163: 38–51, 2023.
Smyth RJ: Ventilatory care in status asthmaticus. Can Respir J. 5: 485–490, 1998.
Laher AE, Buchanan SK: Mechanically ventilating the severe asthmatic. J Intensive Care Med. 33: 491–501, 2017.
Le Conte P, Terzi N, Mortamet G, et al.: Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d’Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies. Ann Intensive Care. 9: 115, 2019.
Pillai AK, Bhatti Z, Bosserman AJ, Mathew MC, Vaidehi K, Kalva SP: Management of vascular complications of extra-corporeal membrane oxygenation. Cardiovasc Diagn Ther. 8: 372–377, 2018.
Schneider TM, Bence T, Brettner F: “Awake” ECCO 2 R superseded intubation in a near-fatal asthma attack. J Intensive Care. 5: 53, 2017.
The Hemolung System: Retrieved on June 20, 2023. https://alung.com/hemolung/.
Bromberger B, Agerstrand C, Abrams D: Extracorporeal carbon dioxide removal in the treatment of status asthmaticus. Crit Care Med. 48: e1226–e1231, 2020.
Singh V, Singh G, Arya RC: Vascular access complication in patients undergoing veno-arterial ECMO and their impact on survival in patients with refractory cardiogenic shock: A retrospective 8-year study. Ann Card Anesth. 25: 171–177, 2022.
Olson SR, Murphree CR, Zonies D, et al.: Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: A systematic review. ASAIO J. 67: 290–296, 2021.
Yeo HJ, Kim D, Jeon D, Kim YS, Rycus P, Cho WH: Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: Analysis of the extracorporeal life support organization registry. Crit Care. 21: 297, 2017.
Tiruvoipati R, Akkanti B, Dinh K, et al.: Extracorporeal carbon dioxide removal with the hemolung in patients with acute respiratory failure: A multicenter retrospective cohort study. Crit Care Med. 51: 892–902, 2023.
Worku E, Schmidt M, Shekar K: Is it time to put low-flow extracorporeal carbon dioxide removal to REST? Crit Care Med. 51: 973–976, 2023.
McNamee J, Gillies M, Barrett N: Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: The REST randomized clinical trial. JAMA. 326: 1013–1023, 2021.
المشرفين على المادة: 142M471B3J (Carbon Dioxide)
تواريخ الأحداث: Date Created: 20231003 Date Completed: 20240501 Latest Revision: 20240501
رمز التحديث: 20240502
DOI: 10.1097/MAT.0000000000002064
PMID: 37788483
قاعدة البيانات: MEDLINE
الوصف
تدمد:1538-943X
DOI:10.1097/MAT.0000000000002064